Potential SARS-CoV-2 main protease inhibitors

The coronavirus disease 2019 (COVID-19) pandemic has prompted an urgent need for new treatment strategies. No target-specific drugs are currently available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but new drug candidates targeting the viral replication cycle are being explor...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, Riddhidev, Perera, Lalith, Tillekeratne, L.M. Viranga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724992/
https://www.ncbi.nlm.nih.gov/pubmed/33309533
http://dx.doi.org/10.1016/j.drudis.2020.12.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724992/
https://www.ncbi.nlm.nih.gov/pubmed/33309533
http://dx.doi.org/10.1016/j.drudis.2020.12.005

Ejemplares similares